As of Friday close, Vascular Biogenics Ltd.’s (NASDAQ:VBLT) stock was down -$0.02, moving down -7.46 percent to $0.26. The average number of shares traded per day over the past five days has been 1,120,280 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.0292 fall in that time frame. In the last twenty days, the average volume was 1,451,640, while in the previous 50 days, it was 1,492,894.
Since last month, VBLT stock retreated -1.23%. Shares of the company fell to $0.2350 on 07/06/23, the lowest level in the past month. A 52-week high of $0.32 was reached on 07/13/23 after having rallying from a 52-week low of $0.10. Since the beginning of this year, VBLT’s stock price has risen by 114.00% or $0.1368, and marked a new high 12 times. However, the stock has declined by -19.75% since its 52-week high.
Valuation Metrics
The stock’s beta is 0.79. Besides these, the trailing price-to-sales (P/S) ratio of 36.10, the price-to-book (PB) ratio of 0.99.
Financial Health
In the three months ended September 29, Vascular Biogenics Ltd.’s quick ratio stood at 3.50, while its current ratio was 3.50, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 90.60% percent. Based on annual data, VBLT earned $0.55 million in gross profit and brought in $0.66 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -146.00%. Return on equity (ROE) for the past 12 months was -96.10%.
While analysts expected Vascular Biogenics Ltd. to report -$0.11 quarterly earnings, the actual figure was -$0.12 per share, beating the consensus estimate by -9.10%. During the quarter, the company generated -$2.69 million in EBITDA. The liabilities of Vascular Biogenics Ltd. were 8.21 million at the end of its most recent quarter ended September 29. The value of shareholders’ equity is $70.5 million.
Technical Picture
This quick technical analysis looks at Vascular Biogenics Ltd.’s (VBLT) price momentum. With a historical volatility rate of 73.23%, the RSI 9-day stood at 37.02% on 04 August.
With respect to its five-day moving average, the current Vascular Biogenics Ltd. price is down by -10.21% percent or -$0.0292. At present, VBLT shares trade -3.13% below its 20-day simple moving average and +74.93% percent above its 100-day simple moving average. However, the stock is currently trading approximately +19.44% above its SMA50 and +85.15% above its SMA200.
Stochastic coefficient K was 36.86% and Stochastic coefficient D was 50.98%, while ATR was 0.0282. Given the Stochastic reading of 24.07% for the 14-day period, the RSI (14) reading has been calculated as 43.62%. As of today, the MACD Oscillator reading stands at -0.0156, while the 14-day reading stands at -0.0139.
Analyst Ratings
Vascular Biogenics Ltd. downgraded its rating on Vascular Biogenics Ltd. (NASDAQ: VBLT) to a Perform in a note to investors on July 20, 2022. The analysts firm previously had an Outperform rating on the stock.Vascular Biogenics Ltd. (VBLT) has been rated Hold by analysts. According to 0 brokerage firms, VBLT is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Vascular Biogenics Ltd. stock as buy, with 0 recommending it as overweight.
With a median target price of $5.00, the current consensus forecast for the stock is $5.00 – $5.00. Based on these forecasts, analysts predict Vascular Biogenics Ltd. (VBLT) will achieve an average price target of $5.00.
